Robert Miller, MD
Neurological Surgery · Lawrence, MANPI 1124250907
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,250 of the $4,427 with a category attached, or 73.4%. 8 manufacturers reported payments, led by Depuy Synthes Products, Inc. at 52.6% of the total. Reporting peaked in 2022 at $1,636 and has fallen 99.8% since, to $4 in 2025. That places this record below the midpoint for neurological surgery clinicians in MA, where the typical reported total is $3,500.
Across 30 payments — averaging $147.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Depuy Synthes Products, Inc.$2K
- Spine Wave, Inc.$1K
- Globus Medical$587
- Johnson & Johnson$172
- Brainlab, Inc.$67
- AbbVie$34
- plus $40 from 2 others
What the payments were for
- Consulting fees$3,25073%
- Travel & lodging$3047%
- Food & beverage$87320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Depuy Synthes Products, Inc. | 3 | $2,329 |
| Spine Wave, Inc. | 4 | $1,198 |
| Globus Medical | 11 | $587 |
| Johnson & Johnson | 7 | $172 |
| Brainlab, Inc. | 1 | $67 |
| AbbVie | 1 | $34 |
| Orthofix Medical, Inc. | 2 | $23 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Spinal Implants$1,000
- Excelsius Robotics System$144
- Sable$137
- ALTERA$127
- Posterior Fixation$123
How this compares
$4,427 in reported general payments places this provider in the 50th percentile of 183 neurological surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbamazepine | 20 | $930 |
| Oxcarbazepine | 16 | $922 |
| Tizanidine Hcl | 50 | $337 |
| Gabapentin | 27 | $330 |
| Pregabalin | 24 | $287 |
| Oxycodone Hcl | 43 | $258 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $161 |
| Methylprednisolone | 13 | $123 |
| Tramadol Hcl | 21 | $105 |
| Diclofenac Sodium | 14 | $87 |
| Diazepam | 15 | $34 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Lawrence
- Simcha WellerBoston$905K
- Paul HouleHyannis$774K
- Aman PatelBoston$734K
- Alireza AtriBoston$503K
- Frederik PenningsWorcester$471K
- Myron RolleBoston$290K
- Jeffrey ArleBurlington$284K
- John ChiBoston$280K
- Matthew PhilipsNorth Dartmouth$247K
- Erica BissonBurlington$240K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.